Viewing StudyNCT00052338



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00052338
Status: COMPLETED
Last Update Posted: 2013-01-23
First Post: 2003-01-24

Brief Title: Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Stage IV Non-small Cell Lung Cancer
Malignant Pleural Effusion
Recurrent Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Keywords: